ArticleAmerican journal of cancer research2021

MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity.

Xiaochen Zhai et al.PubMed ↗Full text ↗

No numbers read from the abstract.